Retrospective analysis of first-line treatment for follicular lymphoma based on outcomes and medical economics

ConclusionR monotherapy for patients whose diseases show low tumor burden and who are not candidates for local treatment has benefits as a first-line treatment compared to R-CHOP, based on the patients ’ QOL and medical economics.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research